Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ultralife (ULBI) Revenue (2016 - 2025)

Ultralife has reported Revenue over the past 16 years, most recently at $48.5 million for Q4 2025.

  • Quarterly results put Revenue at $48.5 million for Q4 2025, up 10.56% from a year ago — trailing twelve months through Dec 2025 was $191.2 million (up 16.24% YoY), and the annual figure for FY2025 was $191.2 million, up 16.24%.
  • Revenue for Q4 2025 was $48.5 million at Ultralife, up from $43.4 million in the prior quarter.
  • Over the last five years, Revenue for ULBI hit a ceiling of $50.7 million in Q1 2025 and a floor of $21.8 million in Q3 2021.
  • Median Revenue over the past 5 years was $39.5 million (2023), compared with a mean of $37.3 million.
  • Biggest five-year swings in Revenue: decreased 17.99% in 2021 and later skyrocketed 52.72% in 2022.
  • Ultralife's Revenue stood at $23.8 million in 2021, then soared by 39.86% to $33.2 million in 2022, then soared by 34.04% to $44.5 million in 2023, then dropped by 1.56% to $43.9 million in 2024, then increased by 10.56% to $48.5 million in 2025.
  • The last three reported values for Revenue were $48.5 million (Q4 2025), $43.4 million (Q3 2025), and $48.6 million (Q2 2025) per Business Quant data.